BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 232824)

  • 1. A case of acute hypercalcaemia followed by a prolonged pulmonary uptake of 99m Tc-pyrophosphate.
    Berkenboom G; Martin P; Gillet C; Schmerber J; Schoutens A
    Acta Tuberc Pneumol Belg; 1979; 70(1):81-5. PubMed ID: 232824
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential skeletal uptake of Tc-99m-tagged pyrophosphate and methylene diphosphonate in leukemia.
    Armas R; Neumann R; Goldsmith SJ
    J Nucl Med; 1983 Sep; 24(9):799-802. PubMed ID: 6310070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced modulation of Tc-99m pyrophosphate tissue distribution: what is involved?
    Wahner HW; Dewanjee MK
    J Nucl Med; 1981 Jun; 22(6):555-9. PubMed ID: 6262466
    [No Abstract]   [Full Text] [Related]  

  • 4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
    Korsunskiĭ VN; Tarasov NF; Koval'chuk ND; Levin VI; Boldyrev PP
    Med Radiol (Mosk); 1980 Sep; 25(9):9-13. PubMed ID: 6252408
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of parathyroid hormone on technetium-99m pyrophosphate distribution in rats.
    Halpern SE; Hagan PL; Chauncey DM; Ayers P
    Eur J Nucl Med; 1980 Dec; 5(6):515-9. PubMed ID: 6257523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative evaluation of the accumulation of 99mTc-labeled phosphate compounds in the bones].
    Atamaniuk NP; Mechev DS
    Eksp Onkol; 1985; 7(1):66-7. PubMed ID: 2983974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dynamics of the change in the mineral component of bone in fractures].
    Sveshnikov AA; Ofitserova NV
    Patol Fiziol Eksp Ter; 1984; (3):53-7. PubMed ID: 6089078
    [No Abstract]   [Full Text] [Related]  

  • 10. [Incorporation of radioactive calcium and technetium pyrophosphate in to bones].
    Markt B; Bergmann G; Raab W; Willvonseder R
    Acta Med Austriaca; 1977; 4(4-9):144-8. PubMed ID: 205073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 99mTc bone scanning agents--II. Adsorption of 99mTc(Sn)pyrophosphate complexes on the mineral phase of bone.
    Kroesbergen J; van Steijn AM; Gelsema WJ; de Ligny CL
    Int J Nucl Med Biol; 1986; 12(6):411-7. PubMed ID: 3011692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal lung uptake of technetium 99m methylene diphosphonate associated with pulmonary emboli and hypercalcaemia.
    Wraight EP
    Br J Radiol; 1983 May; 56(665):345-7. PubMed ID: 6221773
    [No Abstract]   [Full Text] [Related]  

  • 13. [Accumulation of 99m Tc-monofluorophosphate in the bone: experimental study with the special reference to the comparison with 99m Tc-pyrophosphate and 99m Tc-diphosphonate].
    Ichikawa T; Ito Y; Muranaka A; Yokobayashi T; Uchida M
    Kaku Igaku; 1976 Apr; 13(2):129-36. PubMed ID: 184331
    [No Abstract]   [Full Text] [Related]  

  • 14. Liver uptake of 99mTc-pyrophosphate.
    Hansen S; Stadalnik RC
    Semin Nucl Med; 1982 Jan; 12(1):89-91. PubMed ID: 6281916
    [No Abstract]   [Full Text] [Related]  

  • 15. Tc-99m PPi localization in acute experimental myocardial infarction: application of macro- and microautoradiography.
    Tomoike H; Nakamura M; Watanabe K; Inou T; Kurozumi T; Tanaka K
    J Nucl Med; 1982 Jan; 23(1):84-5. PubMed ID: 6275052
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of vitamin D3, other drugs altering serum calcium or phosphorus concentrations, and desoxycorticosterone on the distribution of Tc-99m pyrophosphate between target and nontarget tissues.
    Carr EA; Carroll M; Montes M
    J Nucl Med; 1981 Jun; 22(6):526-34. PubMed ID: 6262465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skeletal muscle uptake of Tc 99m pyrophosphate in amyloidosis.
    Johnston JB; Rayner HL; Trevenen C; Greenberg D
    Am J Hematol; 1982 Nov; 13(3):247-51. PubMed ID: 6295139
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship of mitochondrial alterations and 99mTc pyrophosphate uptake during myocardial ischemia.
    Mukherjee A; Buja LM; Kulkarni P; Nicar M; Chien KR; Willerson JT
    Am J Physiol; 1982 Aug; 243(2):H268-76. PubMed ID: 6287855
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of vitamin D3 on imaging of experimental myocardial infarcts with technetium-99m pyrophosphate: further studies of the role of calcium.
    Carr EA; Carroll M; Gona JM; Balderman SC; Montes M; Steinbach JJ
    J Nucl Med; 1985 Feb; 26(2):157-64. PubMed ID: 2981986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive extraosseous localization of bone imaging agent in a patient with renal failure and rhabdomyolysis accompanied by combined hypercalcemia and hyperphosphatemia.
    Shih WJ; Flueck J; O'Connor W; Domstad PA
    Clin Nucl Med; 1989 Mar; 14(3):163-7. PubMed ID: 2544339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.